DGAP-Media / 2019-03-04 / 07:00
* Reason for the message: Update
Company: * Chemesis International (WKN A2NB26) [1]
* Target price medium term 4.00 EUR
Quarterly revenue of $ 2.8 million increased by more than 47%,
Valuation gap with Khiron Life Sciences will close! *
Just like our Cannabis Top Pick Chemesis International (WKN A2NB26) [1]
was published in the second quarter of 2019, which ended on 31.12.2018,
another record quarter recorded. With $ 2.8 million in sales and one
Gross income of $ 500,000 was far exceeded expectations.
It should be remembered that these sales are largely attributable to
Sales and packaging division Desert Zen. The
Cannabis sales from Puerto Rico, California and Colombia will be ours
Opinion in the coming quarters to a huge sales and
Increase profits.
Currently Chemesis International expects (WKN A2NB26) [1] with a
extremely conservative estimated annual sales for the financial year 2018
(until June 30, 2019) of $ 16.5 million. We are already going from far and wide
higher numbers, since already last week a cannabis
Annual order of $ 4 million for Puerto Rico could be announced.
* Why Chemesis is massively undervalued! *
* - Valuation gap on Khiron Life Sciences will close - *
Also active in Latin America, Khiron Life Sciences (WKN
A2JMZC) [2] is already valued at almost 300 million CAD and that though
does not have a cannabis production in the US and according to the last one
Quarterly report has yet to show any sales. This is our opinion
after another indication that Chemesis International (WKN A2NB26) [1]
is facing a massive revaluation, because currently the company is with
$ 150 million, so one of the most conservative estimates
short-term price reductions absolutely in the range of the possible.
We expect Chemesis to continue its high-altitude flight inexorably
new all-time high on the Canadian home market should be marked soon
We are convinced that very soon the 2 EUR mark
will fall. This is our opinion, however, only the beginning of a
further rally, as it is due to just 17 million shares in the free float
no resistance should give up!
Therefore, we also see ourselves in our medium-term price target of 4 euros
continue to strengthen! The many projects and the great zeal of the work
just the management of Chemesis International (WKN A2NB26) [1] to the day
will make the company one of the largest in 2019
Make cannabis players in the Californian and Latin American market.
* Excerpts from the quarterly report *
Edgar Montero, CEO of Chemesis, stated:
"The company has progressed in all areas of its business plan,
and we look forward to expanding our assets. Chemesis gave
recently announced an annual purchase order of $ 4 million
which in our opinion is just the start. Demand is high there
Consumers and businesses our high quality cultivation and ours
Continue to recognize manufacturing processes. "
Following the quarter end, Chemesis completed the acquisition of La
Finca Interacviva-Arachna Med on January 9, 2019 from. The company expects
his first harvest and the construction of the GMP-certified conveyor system in the
Spring 2019 La Finca raised more than $ 2,000,000 for the company
Working capital.
In addition, the company's manufacturing facility in California has
industrial scale to obtain all necessary licenses and the
Commercialization. The company expects in the coming
Months an increase to the increasing demand on the legal
to meet California's cannabis market.
* Cannabis annual order of over $ 4 million just for Puerto Rico - massive
Expansion!*
Recently, the subsidiary Natural Ventures finalized
Agreement for an annual order worth at least $ 4,000,000
sign. It is therefore not surprising that at the beginning of the week
Entry of a New York hedge fund was announced, which another 5.8
Million dollars for aggressive expansion. We expect in the
Year 2019 a significant increase in sales and earnings prospects,
accompanied by a significant price increase.
The company is working for a Puerto Rico-based pharmacy network in
its fully licensed and with the state regulations
compliant plant cultivation, manufacturing, packaging and distribution
carry out. The products are according to the pharmacy brands
White products and are delivered weekly. First orders in
Values of over $ 400,000 were settled in February and traded with the
weekly increases in patient numbers in Puerto Rico await both
Increased their demand at the beginning of the second quarter of 2019.
"Chemesis has a strong relationship with retail sales
focused team and we will provide a supply of their pharmacies
with high-quality cannabis products, "said the CEO of
Chemesis, Edgar Montero. "Natural Ventures has the solidification of its reputation as
a high-quality breeder and manufacturer of cannabis products continued
and we see this order as a confirmation. Furthermore, this is expected
Companies to see an increase in monthly orders because more
Pharmacies on the island will be opened. "
* Even though we already have a significant increase in prices in recent weeks
have seen the full potential is far from exhausted.
An increase of 200% and more is still possible! *
* Chemesis massively expands production facility in California! *
As Chemesis International (WKN A2NB26) [1] recently announced
The company will build its manufacturing facility in Cathedral, California
City massively expand. So should the production area by additional 25,000
Square feet are extended and that until the end of the second
Quarterly 2019.
This expansion allows Chemesis International (WKN A2NB26) [1] the
to expand once again offered product portfolio. To this
Portfolio includes cannabis products for the beverage, food and beverage
Consumer sector. The demand of the California cannabis market has the
Expectations far exceeded, said Edgar Montero, CEO of Chemesis.
As the Californian market is one of the company's main pillars,
one rejoices, through the newly created production area the
Performance and production capacity especially for this important
Market increase.
For Chemesis International (WKN A2NB26) [1] this means a clear one
noticeable increase in sales and profits. If you take them alone
The new extraction process generated revenue growth of $ 2.4 million as
Scale, let's assume a true turnover explosion for that
Fiscal year 2019. Mind you, this $ 2.4 million resulted
a single order, far more will follow in the next few weeks.
Currently Chemesis International expects (WKN A2NB26) [1] with a
extremely conservative estimated annual sales for the financial year 2018
(until June 30, 2019) of $ 16.5 million. We are already going from far and wide
higher numbers.
Due to the outstanding work of Chemesis International (WKN A2NB26)
[1] 2019 several projects can be realized. After
Extension of the production facility in California for the 2nd quarter
2019 is expected, the production plant in Colombia in operation
go. Chemesis is working hard in all areas to do this
Company continues to evolve and become one of the biggest cannabis
Provider for the Californian and Latin American cannabis market too
do.
* In our estimation, Chemesis will already be available for the financial year 2019
can show three-digit sales figures! Therefore, we continue to see
the potential for a price increase around the 4 euro mark given! Use
so your chance for 200% plus and more! *
Here you can subscribe to our free newsletter - LINK [3]
* Stock price broken out! 12% plus after yesterday's sensation report -
Further rise is imminent! *
Chemesis International (WKN A2NB26) [1] yesterday announced the launch of a
new production method for the production of cannabis products. The
Closing the company then subscribed to the Canadian
Home market up 12% in plus. It seems like the stock finally has the
Resistance barrier breached the price in recent weeks at 1.60
CAD has held. The way to a new all-time high far beyond the 2 CAD
Brand is free in our opinion!
If you take a closer look at the course of the Last Months, it now seems
to face the final outbreak. The important 2 CAD brand already
was cracked last year in September, should fall today. After that
are likely, with just about 17 million shares in the free float, no resistance
more to be expected!
* Target price 4 Euro - These are the reasons for our assessment! *
(MORE TO FOLLOW) Dow Jones Newswires
March 04, 2019 01:00 ET (06:00 GMT)
At first glance, our issued price target of 4 euros seems very
ambitious. But the outstanding work that Chemesis International (WKN
A2NB26) [1] in recent months, ours confirm
Assessment all the more. We have the developments here again
summarized:
- Acquisition of a revolutionary cannabis extraction process with production
in California. $ 2.4 million in sales through this new technology alone!
- Sales ($ 16.5 million) and earnings estimate ($ 2 million) by the end of the
Fiscal year on 30 June 2019 are already through the recent acquisitions
now exceeded.
- Chemesis is in three extreme fast growing cannabis markets
California, Puerto Rico and Colombia
- made mega-acquisition with over 4 million square meters of acreage in Colombia
Chemesis the largest cannabis producer in terms of area
Latin America. Construction of a GMP certified cannabis extraction plant with
certified production lab starts in the first quarter of 2019
- The Latin American market offers huge development potential
and is expected to have a market volume of $ 4.2 billion by 2028.
Chemesis has positioned itself well in advance of this
To benefit from development.
Chemesis has a broad product portfolio for the
corresponding market matching products such as cannabis oils, medical
To offer cannabis or supplements
- By taking over already bursting local cannabis producers,
The entry into the cannabis beverage and food sector was perfect
made and promptly first cannabis products are manufactured and sold.
- For marketing purposes, among others, just in the US as
"Silent Bob" well-known actor and director Kevin Smith won
become. Alone through its social media presence with over 12.4 million
Followers Chemesis increases its awareness for cannabis users.
The newly introduced cannabis brand "Jay an Silent Bob" has in the first
Sales week has already reached an order volume of over $ 100,000.
* Summarizing all these points, the current rating is the
* Chemesis International (WKN A2NB26) [1] * with 160 million CAD much too cheap.
Comparable companies currently have a market capitalization
of at least $ 500 million. The time, this enormous catch-up potential
to exhaust, has started yesterday's rise in price. Secure yourself
Therefore, now the chance to over 100% increase in value!
Here you can subscribe to our free newsletter - LINK [3]
* Enormous sales and profit increase! Chemesis is licensing groundbreaking
Cannabis extraction procedure! Share before eruption! *
Extremely positive news reports our cannabis top
PickChemesis International (WKN A2NB26) [1]. The company announces the acquisition
a breakthrough technology for extraction of cannabis oils and others
Known products. The genius of this method is the low
Temperature under which it is carried out. Usually go with the
usual extraction methods lost many active ingredients of the cannabis plant.
The new process, however, receives all phyto-cannabinoids and terpenes and
thus allows the production of cannabis products in unprecedented levels
Quality.
Chemesis International (WKN A2NB26) [1] will replace the existing ones
Extraction equipment in its production facility in the US state of California
Install and join the procedure
involved employees also make use of the necessary know-how. The
previous product range of ethanol and butane hashish oil process (BHO)
Produced products intended to contain tinctures, shatters, vapes, oils and
be significantly extended to other consumer products of the new process.
Another positive side effect of the new extraction method is the 100
Conservation of natural cannabinoids, which is essential
higher yield of cannabis products allows. Furthermore, can be enormous
Savings can be achieved by reducing operating costs. Makes possible
this is the shortening of the extraction process, in which no
Overwintering, filtration and evaporation of cannabis plants needed
is.
Due to the new products, Chemesis International (WKN A2NB26) [1] has a
serve even larger parts of the California cannabis market. Already
Now the company has monthly orders of $ 200,000
for products made using the new process. This
alone results in $ 2.4 million more sales per year!
* Due to the greater supply, the increased demand and the
Reducing costs, we expect a significant increase in sales
and profit already in this quarter! With the new extraction process
* Chemesis International (WKN A2NB26) [1] * is one of the best
established cannabis producers in the US and Latin American markets.
Doubling the current price is therefore only a matter of time and time
would correspond to a fair valuation of the company. *
Here you can subscribe to our free newsletter - LINK [3]
* Construction of a GMP-certified cannabis extraction plant for export
Colombia - additional million sales expected! *
Recently, we reported that our cannabis top PickChemesis
International (WKN A2NB26) [1] still in the first quarter of 2019 with the construction of a
GMP-certified cannabis extraction plant in Colombia.
The state-of-the-art facility will house a certified production laboratory
that has a large production capacity for both the domestic as well
also own the international markets.
Chemesis has a compelling track record in construction and design
the operation of compliant extraction laboratories in various international
Markets, as shown in California and Puerto Rico. The enterprise
will leverage its first-time-provider advantage in Colombia where currently
There is a shortage of certified extraction equipment. At the start of construction of
La Finca's current 1,060 acre (equivalent to
43 million sq. Ft) of extensive acreage. The targeted 16.5 million
USD sales until the end of the current fiscal year (as at 30.06.2019)
therefore, in our opinion, a most conservative estimate there, we
expect significantly higher sales.
We expect more significant news in the coming weeks, currently
one works on many fronts - an outbreak over the 2 euro mark is
in our opinion, only a matter of time. Remember, due
The high insider participation is only 16 million shares in the free float.
A fast, huge price increase is therefore absolutely in the range of
Possible.
* All in all * Chemesis International (WKN A2NB26) [1] * complies with the
excellent strategic direction and very smart acquisitions the
Requirements to become the high flyer in the cannabis sector in 2019.
Due to the success of the company also the industry sizes like
Canopy Growth * (WKN A140QA) [4] * or Aphria * (WKN A12HM0) [5] * on Chemesis
become attentive. *
* Therefore, Chemesis expects the end of the current fiscal year on June 30th
2019 with a total revenue of $ 16.5 million and a gain of approximately 2
Million USD. What an exceptionally good thing for such a young company
Result represents. *
Since Chemesis International (WKN A2NB26) [1] already for the fiscal year
In 2020, with a tripling of sales and profits, one is
Revaluation of the stock far above the current price level more than
entitled. A course to the 4 euros is quite possible.
* The news in detail: *
The company also announces that La Finca is a seed producer
License (Seed Production License). La Finca received before
A short inspection by the ICA (Colombian Ministry of Agriculture,
Colombian Ministry of Agriculture). During the visit
La Finca demonstrated full compliance and regulations
Infrastructure requirements for the award of this license. According to
ICA regulations will require La Finca to carry out additional
work towards agronomic evaluations. Upon completion, the company becomes
have permission to commercial scale crops in regions of the
across the country.
As previously announced, the company is using Universidad
Nacional de Colombia continue the partnership to be ideal
Planting densities for biomass, yield improvement, ideal seed varieties
for each climate zone and harvesting techniques. Further investigate that
Company and the university growing cannabis in greenhouses for
Flowers with higher CBD content. These first research, cultivation and
Harvesting work at La Fincas will be 10,000 square feet in size
Greenhouse done.
"We are with La Finca and the success they have in such a short time
have achieved, very satisfied, "said CEO, Edgar Montero." The certified
Extraction plant of the company will allow the company, both
the domestic as well as the international markets with a variety of
Finished products for its own brands and third-party brands
supply."